It can be seen from analysis on major blood grouping analyzer-related patent applications published in the 3 years from 2018 to 2021 that benefited from the basically stable original technologies of the industry; domestic enterprises have continuously increased R&D inputs, constantly improved technical innovation capability, made breakthroughs in many technologies, and developed a batch of core components of instruments with independent intellectual property rights through follow-on R&D strategy.

China plans to accelerate the establishment of a tiered healthcare delivery system, focusing on strengthening primary-level medical capacity to manage common and chronic diseases such as hypertension and diabetes, authorities said.

ANP Technologies announced on Monday that its SARS-CoV-2 rapid antigen test has received Emergency Use Authorization from the US Food and Drug Administration.

Sensor developer TE Connectivity announced on Sunday that it has acquired three companies to further expand its business into the in vitro diagnostic arena.

Novacyt on Monday reported a nearly 15 percent year-over-year decrease in revenues for the first half of 2021 as the French diagnostics firm held off on including revenues generated under a disputed SARS-CoV-2 test supply contract with the UK Department of Health and Social Care.

Beckman Coulter Life Sciences said on Monday that it has entered into an agreement with Invitae to develop applications for Beckman's new next-generation sequencing library preparation system.

On September 23, FDA sent a letter to all manufacturers that received EUA authorization for COVID-19 tests, urgently notifies all these manufacturers of three new requirements for their EUA-authorized tests.

GE (NYSE:GE) has entered into an agreement to acquire BK Medical, a leader in advanced surgical visualization, from Altaris Capital Partners for a cash purchase price of $1.45 billion.

On September 26, Hangzhou Matridx Biotechnology Co., Ltd. (hereinafter referred to as Matridx) announced that it had completed a strategic investment of hundreds of millions of yuan.

Lucid Diagnostics on Thursday announced a proposed initial public offering of its common stock.

Zymo Research announced on Thursday that its EZ DNA Methylation-Lightning Kit has received CE marking.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (“Mindray”) (300760.SZ), a leading global provider of medical devices and solutions, has completed its previously announced acquisition of HyTest Invest Oy and its subsidiaries (“HyTest”), a global leading provider of antibodies and antigens.